about
The role of regulatory T cells in the pathogenesis of sepsis and its clinical implicationThe emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation.Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.Challenges facing adjuvants for cancer immunotherapy.Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.Assessment of Some Immune Parameters in Occupationally Exposed Nuclear Power Plant Workers: Flow Cytometry Measurements of T Lymphocyte Subpopulations and Immunoglobulin Determination.Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells.Glioma-specific antigens for immune tumor therapy.Effect of nutrient starvation on proliferation and cytokine secretion of peripheral blood lymphocytes.Dendritic cell-based immunotherapy of malignant melanoma: success and limitations.CD4+ CD25+ regulatory T cells: a therapeutic target for liver diseases.Regulatory T cells and human diseaseMultiple roles for CD4+ T cells in anti-tumor immune responses.How tumours escape mass destruction.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.T-cell-mediated antitumor immunity in B-cell non-Hodgkin lymphoma: activation, suppression and exhaustion.Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.Characteristics of CD4(+)CD25(+)Foxp3(+) regulatory T cells in patients with multiple organ dysfunction syndrome.Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells.Prognostic value of peripheral and local forkhead box P3(+) regulatory T cells in patients with non-small-cell lung cancer.
P2860
Q27004368-67871957-9FBB-4E7B-8553-72F34B945DD5Q35058213-29EC04F8-2C86-4AF8-B88F-1FE5837AD1C4Q35553324-BD060F43-04BB-406E-A571-67C0FB10B6D5Q35835489-F9D3D468-2F78-433F-9AF9-C943A814A91FQ35953773-4CEF2ADC-BAFF-4555-8859-253B9CB98E09Q36336136-04692F7D-63DA-451B-9039-737112ADE22CQ36371971-1B595D3A-08B2-4D62-A206-AE6BEBA3C069Q36399686-71B0A169-098B-4BCA-B8FE-84DAA5F7194DQ36690281-374C6A41-8029-47C3-B93D-382133289B1DQ36741045-C10FD26F-1756-4EA1-9F32-2B0AC3337584Q36752195-A147DAF5-0101-418B-9FF2-196404B9FCDCQ37082777-C896CBAE-4768-4E02-81C0-F660C3A0E0EEQ37101255-2461F3AA-2ECB-41B7-B1BE-C2CF67494B02Q37118150-9525FED6-B03F-4D5C-B2AF-EC6F693BA5FDQ37287162-F56335A0-765E-493B-8C28-E93631BD95F6Q37798839-915EC8FE-FD5A-4E5E-BBC4-18F18E1857C0Q38253084-5D355192-A916-41C2-B707-7838CF323CE7Q38344066-32AD2A98-1135-4090-8DFE-BF1121675B46Q39418860-8F6BA467-9562-40AC-9E69-3F63EA0BD891Q39472057-626E5DB3-7111-4DD0-B752-812FA06F89D7Q39535683-BF02BA30-072C-4A47-8DC1-F35A8317C594Q39734928-0BC83BA5-86D4-471F-8921-FC1060D841A2Q40486270-4C6046E8-B901-4465-ABBB-6B2F887F2904Q41543718-60E5DD12-03EA-4529-B499-63C57F1E6682Q41895496-74D67637-AD87-493E-8B6E-202EF95E24B4Q42743141-1F566D2D-7D02-4D2A-8181-74946B3B98D0
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Regulation of tumour immunity by CD25+ T cells.
@ast
Regulation of tumour immunity by CD25+ T cells.
@en
Regulation of tumour immunity by CD25+ T cells.
@nl
type
label
Regulation of tumour immunity by CD25+ T cells.
@ast
Regulation of tumour immunity by CD25+ T cells.
@en
Regulation of tumour immunity by CD25+ T cells.
@nl
prefLabel
Regulation of tumour immunity by CD25+ T cells.
@ast
Regulation of tumour immunity by CD25+ T cells.
@en
Regulation of tumour immunity by CD25+ T cells.
@nl
P2860
P1433
P1476
Regulation of tumour immunity by CD25+ T cells.
@en
P2093
Awen Gallimore
Shimon Sakaguchi
P2860
P356
10.1046/J.1365-2567.2002.01471.X
P577
2002-09-01T00:00:00Z